vs
Side-by-side financial comparison of USANA HEALTH SCIENCES INC (USNA) and WSFS FINANCIAL CORP (WSFS). Click either name above to swap in a different company.
WSFS FINANCIAL CORP is the larger business by last-quarter revenue ($275.3M vs $226.2M, roughly 1.2× USANA HEALTH SCIENCES INC). WSFS FINANCIAL CORP runs the higher net margin — 31.5% vs 0.1%, a 31.4% gap on every dollar of revenue. On growth, WSFS FINANCIAL CORP posted the faster year-over-year revenue change (7.5% vs -10.0%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (3.1% CAGR vs 1.7%).
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
WSFS Financial Corporation is a financial services company. Its primary subsidiary, WSFS Bank, a federal savings bank, is the largest and longest-standing locally managed bank and wealth management franchise headquartered in Delaware and the Greater Delaware Valley. WSFS operates from 115 offices, 88 of which are banking offices, located in Pennsylvania (57), Delaware (39), New Jersey (14), Florida (2), Virginia (1), and Nevada (1) and provides comprehensive financial services including comme...
USNA vs WSFS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $226.2M | $275.3M |
| Net Profit | $180.0K | $86.8M |
| Gross Margin | 78.2% | — |
| Operating Margin | 1.7% | — |
| Net Margin | 0.1% | 31.5% |
| Revenue YoY | -10.0% | 7.5% |
| Net Profit YoY | -74.0% | 31.7% |
| EPS (diluted) | $-0.10 | $1.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $275.3M | ||
| Q4 25 | $226.2M | $271.9M | ||
| Q3 25 | $213.7M | $270.5M | ||
| Q2 25 | $235.8M | $267.5M | ||
| Q1 25 | $249.5M | $256.1M | ||
| Q4 24 | $213.6M | $261.5M | ||
| Q3 24 | $200.2M | $267.7M | ||
| Q2 24 | $212.9M | $266.0M |
| Q1 26 | — | $86.8M | ||
| Q4 25 | $180.0K | $72.7M | ||
| Q3 25 | $-6.5M | $76.4M | ||
| Q2 25 | $9.7M | $72.3M | ||
| Q1 25 | $9.4M | $65.9M | ||
| Q4 24 | $4.5M | $64.2M | ||
| Q3 24 | $10.6M | $64.4M | ||
| Q2 24 | $10.4M | $69.3M |
| Q1 26 | — | — | ||
| Q4 25 | 78.2% | — | ||
| Q3 25 | 77.2% | — | ||
| Q2 25 | 78.7% | — | ||
| Q1 25 | 79.0% | — | ||
| Q4 24 | 82.0% | — | ||
| Q3 24 | 80.4% | — | ||
| Q2 24 | 81.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.7% | 35.8% | ||
| Q3 25 | 0.6% | 37.3% | ||
| Q2 25 | 7.1% | 35.7% | ||
| Q1 25 | 6.3% | 34.0% | ||
| Q4 24 | 3.8% | 32.3% | ||
| Q3 24 | 7.8% | 31.9% | ||
| Q2 24 | 8.4% | 34.0% |
| Q1 26 | — | 31.5% | ||
| Q4 25 | 0.1% | 26.7% | ||
| Q3 25 | -3.1% | 28.3% | ||
| Q2 25 | 4.1% | 27.0% | ||
| Q1 25 | 3.8% | 25.7% | ||
| Q4 24 | 2.1% | 24.6% | ||
| Q3 24 | 5.3% | 24.1% | ||
| Q2 24 | 4.9% | 26.0% |
| Q1 26 | — | $1.64 | ||
| Q4 25 | $-0.10 | $1.33 | ||
| Q3 25 | $-0.36 | $1.37 | ||
| Q2 25 | $0.52 | $1.27 | ||
| Q1 25 | $0.49 | $1.12 | ||
| Q4 24 | $0.23 | $1.08 | ||
| Q3 24 | $0.56 | $1.08 | ||
| Q2 24 | $0.54 | $1.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.4M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $2.7B |
| Total Assets | $742.9M | $22.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $158.4M | $1.7B | ||
| Q3 25 | $145.3M | — | ||
| Q2 25 | $151.3M | — | ||
| Q1 25 | $179.6M | — | ||
| Q4 24 | $181.8M | $1.2B | ||
| Q3 24 | $364.9M | — | ||
| Q2 24 | $332.4M | — |
| Q1 26 | — | $2.7B | ||
| Q4 25 | — | $2.7B | ||
| Q3 25 | $528.1M | $2.8B | ||
| Q2 25 | $531.1M | $2.7B | ||
| Q1 25 | $529.8M | $2.7B | ||
| Q4 24 | $532.1M | $2.6B | ||
| Q3 24 | $533.1M | $2.7B | ||
| Q2 24 | $512.2M | $2.5B |
| Q1 26 | — | $22.1B | ||
| Q4 25 | $742.9M | $21.3B | ||
| Q3 25 | $726.6M | $20.8B | ||
| Q2 25 | $734.5M | $20.8B | ||
| Q1 25 | $746.6M | $20.5B | ||
| Q4 24 | $748.2M | $20.8B | ||
| Q3 24 | $671.3M | $20.9B | ||
| Q2 24 | $631.4M | $20.7B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
